Virus Inactivation by Formaldehyde and Common Lysis Buffers

Author:

Seeburg Ulrike1,Urda Lorena1ORCID,Otte Fabian1ORCID,Lett Martin J.1,Caimi Silvia1,Mittelholzer Christian1ORCID,Klimkait Thomas1ORCID

Affiliation:

1. Molecular Virology, Department Biomedicine, University of Basel, 4009 Basel, Switzerland

Abstract

Numerous mammalian viruses are routinely analyzed in clinical diagnostic laboratories around the globe or serve as indispensable model systems in viral research. Potentially infectious viral entities are handled as blood, biopsies, or cell and tissue culture samples. Countless protocols describe methods for virus fixation and inactivation, yet for many, a formal proof of safety and completeness of inactivation remains to be shown. While modern nucleic acid extraction methods work quite effectively, data are largely lacking on possible residual viral infectivity, e.g., when assessed after extended culture times, which maximizes the sensitivity for low levels of residual infectiousness. Therefore, we examined the potency and completeness of inactivation procedures on virus-containing specimens when applying commonly used fixatives like formaldehyde or nucleic acid extraction/lysis buffers. Typical representatives of different virus classes, including RNA and DNA viruses, enveloped and non-enveloped, such as adenovirus, enterovirus, lentivirus, and coronavirus, were used, and the reduction in the in vitro infectiousness was assessed for standard protocols. Overall, a 30-minute incubation with formaldehyde at room temperature effectively inactivated all tested enveloped and non-enveloped viruses. Full inactivation of HIV-1 and ECHO-11 was also achieved with all buffers in the test, whereas for SARS-CoV-2 and AdV-5, only five of the seven lysis buffers were fully effective under the tested conditions.

Publisher

MDPI AG

Subject

Virology,Infectious Diseases

Reference14 articles.

1. (2023, July 24). Classification of Organisms (Switzerland). Available online: https://www.bafu.admin.ch/bafu/en/home/topics/biotechnology/publications-studies/publications/classification-of-organisms.html.

2. (2023, July 24). Guidelines on Viral Inactivation and Removal Procedures Intended to Assure the Viral Safety of Human Blood Plasma Products. Available online: https://www.who.int/publications/m/item/WHO-TRS924-Annex4.

3. (2023, July 24). ICH Guideline Q5A(R2) on Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal Origin-Scientific Guideline. Available online: https://www.ema.europa.eu/en/ich-guideline-q5ar2-viral-safety-evaluation-biotechnology-products-derived-cell-lines-human-animal.

4. (2023, July 24). Virus Safety Evaluation of Biotechnological Investigational Medicinal Products-Scientific Guideline. Available online: https://www.ema.europa.eu/en/virus-safety-evaluation-biotechnological-investigational-medicinal-products-scientific-guideline.

5. Evaluation of stability and inactivation methods of SARS-CoV-2 in context of laboratory settings;Widera;Med. Microbiol. Immunol.,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3